Moira speaks with psychologist Dr. Ron Friedman about “Decoding Greatness … How the Best in the World Reverse Engineer Success”. Then Dr. Tom Hallam from Palisade Bio in San Diego talks about their efforts to solve a major problem post-surgery – how to get your GI track back on track. And Tech Nation Health Chief Correspondent Dr. Daniel Kraft reviews tests to detect Alzheimer’s early.

Bill then discussed some of the current applications of the TFF technology – including enhancing the stability of Takeda Vaccine’s norovirus vaccine. “We laid out the premise that in the liquid form, or even the frozen form, that the antigen was losing activity… but in the paper we showed that through TFF this norovirus vaccine could be stabilised – we are up to several months at 40°C,” he enthused, an amazing achievement since most vaccines require cold chain storage and Pfizer and BioNTech’s mRNA COVID-19 vaccine required ultra-low refrigeration (-70°C or -80°C) to be distributed originally.

Koenraad Wiedhaup, Founder and CEO of Leyden Labs, and his team have taken a proactive approach to overcome the challenges of protecting people from known viruses and new viruses. They are developing intranasal sprays containing biological molecules that can temporarily protect against a broad range of viruses.  This approach is between a vaccine that often gives long-term protection and a therapeutic necessary once someone is infected.

Anima Biotech has developed a platform that allows it to use small molecule that selectively control mRNA and can decrease or increase the translation of proteins.